Multiple Myeloma Archives - Cancer Therapy Advisor

Multiple Myeloma

Pazopanib may be similar to sunitinib in terms of clinical efficacy for treating metastatic renal ce

Comparing Efficacy and Safety of Auto-HCT in Older and Younger Patients With Multiple Myeloma

The efficacy and safety of autologous hematopoietic stem cell transplantation (auto-HCT) performed during the era of novel agents was comparable between elderly and younger patients with multiple myeloma, according to results of a retrospective study published in Bone Marrow Transplantation. Uncertainty remains regarding the risks and benefits of auto-HCT in elderly patients (≥ 65 years).…

Researchers proposed lowering the circulating plasma cell threshold from 20% to 5% for plasma cell l

clonoSEQ and MRD Testing in Multiple Myeloma and ALL

Medicare coverage has been announced for Adaptive Biotechnologies’ clonoSEQ® next-generation sequencing assay for the detection of minimal residual disease (MRD) after treatment for multiple myeloma or B-cell acute lymphoblastic leukemia (ALL) — a key step toward its use for patient care in cancer clinics in the United States.1,2The FDA announced regulatory approval for the assay…

Thawing Frozen Cancer Drug Labels

As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…

Next post in General Oncology